Augustine Therapeutics Company Profile, Contacts & Intelligence

Biotechnology ResearchLeuven, Vlaams Brabant, Be24 employeesFounded 2019
3 contacts with email or phone data3 with email data1 with phone data
View verified contacts Compare competitors
Employees
24
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts
Departments
1
Mapped contact coverage

Augustine Therapeutics Overview

Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.

Headquarters
Leuven, Vlaams Brabant, Be
Website
augustinetx.com
Industry
Biotechnology Research
Founded
2019
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Company Email
Available in AeroLeads
in peripheral neuropathy.

Augustine Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 1 with phone data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
General
1

Augustine Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

V
Virginie Cartage
E
R
Rie Schultz Hansen
P
Pascale Witz
Chair, Board Director, Advisor, Former CEO, Investor, Author / Pharma & Biotech, Digital Health, Medtech
EP
E
Emmanuelle Coutanceau
Partner at Novo Holdings
E

Augustine Therapeutics Workforce Composition

Seniority breakdown across 3 visible profiles.

Executive
1
VP / Head
1
Individual contributor
1

Compare Similar Companies to Augustine Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Confo Therapeutics Biotechnology 77 View company
Agomab Biotechnology Research 68 View company
Averna Therapeutics Biotechnology Research 48 View company
Character Biosciences Biotechnology 44 View company
Hillstar Bio Biotechnology Research 23 View company
Rewind Therapeutics Biotechnology Research 19 View company
Flamingo Therapeutics Biotechnology Research 18 View company
Asabys Partners Venture Capital And Private Equity Principals 16 View company
Montis Biosciences Biotechnology Research 16 View company
Tempero Bio Biotechnology Research 6 View company